GSK pledges $30bn US investment as UK’s pharma woes deepen

GSK rebrands to Haleon Kenya after separation

GSK profits from vaccines, HIV drugs

GSK profit slides on Haleon split, Covid drug sales slump

Drugmaker GSK profit rockets on consumer health spinoff